(Q37756144)

22 August 2017

1 reference

title

Extended-release lamotrigine in the treatment of patients with epilepsy (English)

1 reference

22 August 2017

1 reference

Tanvir U Syed

1

1 reference

22 August 2017

Martha Sajatovic

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

published in

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

9

1 reference

22 August 2017

page(s)

1579-1585

1 reference

Prevalence of self-reported epilepsy, health care access, and health behaviors among adults in South Carolina

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Prevalence of active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Mortality of epilepsy in developed countries: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Cause-specific mortality in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Seizure-related injury and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Survival of patients with epilepsy: an estimate of the mortality risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Mortality in patients with epilepsy: a study of patients in long term residential care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Life-long history of injuries related to seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

The association of stigma with self-management and perceptions of health care among adults with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Clinical pharmacology and pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Management of prolonged seizures and status epilepticus in childhood: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Once-daily lamotrigine extended release for epilepsy management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Lamotrigine is an open-channel blocker of the nicotinic acetylcholine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Lamotrigine clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Oral contraceptives reduce lamotrigine plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Lamotrigine extended-release as adjunctive therapy for partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

Managing patient adherence and quality of life in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485611

10.1517/14656566.2010.485611

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference